SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |